Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16084539 | 0.78 | — | — | |
| SCHEMBL26084658 | 0.76 | KDM4E (0.31) | — | |
| SCHEMBL26770215 | 0.76 | EPHX1 (0.33) | — | |
| SCHEMBL11807873 | 0.75 | HRH4 (0.32) | HRH4HRH3ADRB2HTR1BNR2E1 | |
| SCHEMBL2866747 | 0.75 | — | — | |
| SCHEMBL14848714 | 0.74 | EPHX1 (0.32) | — | |
| SCHEMBL8621578 | 0.72 | HRH4 (0.33) | HRH4HRH3ADRB2HTR1BNR2E1 | |
| SCHEMBL15981492 | 0.71 | HRH4 (0.34) | HRH4HRH3ADRB2 | |
| SCHEMBL432341 | 0.71 | CA12 (0.44) | — | |
| SCHEMBL29169937 | 0.71 | EPHX1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170135911-A1 | CURABLE COMPOSITIONS AND METHODS FOR ISOLATING A WORKING AREA | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-05-18 | — | — | US | disclosed |
| US-9139753-B2 | Single-component moisture-curable coatings based on N-substituted urea polymers with extended chains and terminal alkoxysilanes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140275405-A1 | SINGLE-COMPONENT MOISTURE-CURABLE COATINGS BASED ON N-SUBSTITUTED UREA POLYMERS WITH EXTENDED CHAINS AND TERMINAL ALKOXYSILANES | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170135911-A1 | CURABLE COMPOSITIONS AND METHODS FOR ISOLATING A WORKING AREA | BCCIP, EPM2A, EMD | HRH4 3600/4885HRH3 2035/4885ADRB2 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.